News
Novo Nordisk Adds Ozempic to Direct-to-Consumer Offerings
Digest more
GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new ...
GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click ...
Patients who are prescribed Wegovy or Ozempic can now use GoodRx to access the medications at just $499 a month if they skip ...
22hon MSN
Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients
Who benefits? The reduced price applies to self-paying patients—those without insurance, or whose insurance doesn’t cover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results